COMMUNIQUÉS West-GlobeNewswire

ContraVir Pharmaceuticals Announces Data on Optimized Formulation of TXL™

21/06/2018 - 14:00

EDISON, N.J., June 21, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]

Inovio Announces Treatment of First Patient in Immuno-Oncology Study for Glioblastoma (GBM) with INO-5401 in Combination with Regeneron’s PD-1 Inhibitor

21/06/2018 - 14:00

Phase 1/2 clinical trial combines Regeneron’s PD-1 inhibitor cemiplimab and Inovio’s immunotherapy INO-5401 in brain cancer PLYMOUTH MEETING, Pa., June 21, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: [...]

Cynata Reports Positive 28-day Data From Cohort B of Phase 1 Trial of CYP-001 in GvHD

21/06/2018 - 14:00

MELBOURNE, Australia, June 21, 2018 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine company Cynata Therapeutics Limited (ASX:CYP) is pleased to announce positive safety and efficacy data from a day 28 [...]

PolarityTE Appoints Paul Mann of Highbridge Capital to Chief Financial Officer

21/06/2018 - 14:00

Current PolarityTE CFO John Stetson will Become Chief Investment Officer of the Company and President of a New Strategic Arm—PolarityIS SALT LAKE CITY, June 21, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq:COOL) [...]

Cellular Biomedicine Group to Present a Keynote Address at CAR-TCR Summit Asia

21/06/2018 - 13:30

SHANGHAI, China and CUPERTINO, Calif., June 21, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc . (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of [...]

Marinus Pharmaceuticals to Be Added to the Russell 2000 and Russell 3000 Index

21/06/2018 - 13:30

Marinus’ addition to the indexes will be effective June 22, 2018, after market close RADNOR, Pa., June 21, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (the “Company”, “Marinus”), a [...]

Syneos Health and Elligo Announce Strategic Collaboration to Advance Clinical Research for Real-World Patients

21/06/2018 - 13:30

AUSTIN, Texas and RALEIGH, N.C., June 21, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and Elligo Health Research , the only platform that [...]

Moleculin Announces $2.3 Million Registered Direct Offering Priced At-the-Market

21/06/2018 - 13:30

HOUSTON, June 21, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (NASDAQ:MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of anti-cancer drug candidates, all of [...]

Crinetics Pharmaceuticals Awarded up to $3.2 Million in SBIR Grants for Congenital Hyperinsulinism and Acromegaly

21/06/2018 - 13:30

SAN DIEGO, June 21, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine [...]

The Joint Corp. CFO to Depart in July

21/06/2018 - 13:05

SCOTTSDALE, Ariz., June 21, 2018 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ:JYNT), a national operator, manager and franchisor of chiropractic clinics, reported CFO John Meloun will resign effective July 20, 2018. [...]

Top-Five National Payer Issues Positive Coverage Decision for Myriad’s Prolaris® Test for Prostate Cancer

21/06/2018 - 13:05

Decision Follows Recently Updated Medical Guidelines for Prostate Cancer SALT LAKE CITY, June 21, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine [...]

Voyager Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted for VY-AADC for the Treatment of Parkinson’s Disease

21/06/2018 - 13:03

CAMBRIDGE, Mass., June 21, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases today [...]

Surface Oncology Recognized as one of the “Best Places to Work” by Boston Business Journal

21/06/2018 - 13:00

CAMBRIDGE, Mass., June 21, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today [...]

BeyondSpring Provides Operational Updates and First-Quarter 2018 Financial Results

21/06/2018 - 13:00

NEW YORK, June 21, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the Company) (NASDAQ:BYSI), a global, clinical-stage biopharmaceutical company focused on the development of transformative cancer therapies, today [...]

The Hydropothecary Corporation Announces Graduation to the TSX, Shareholder Meeting for Rebranding to HEXO

21/06/2018 - 12:30

GATINEAU, Quebec, June 21, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (“THCX” or the “Company”) (TSX-V:THCX) announced today that it has received approval from the Toronto Stock Exchange (the “TSX”) to [...]

Inscription de la société Hydropothecary à la TSX et assemblée des actionnaires concernant la nouvelle marque HEXO

21/06/2018 - 12:30

GATINEAU, Québec, 21 juin 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (« THCX » ou la « Société ») (TSX-V:THCX) a annoncé aujourd’hui qu’elle a reçu l’approbation de la Bourse de Toronto (la « TSX ») lui [...]

Key Day 100 Survival Outcomes of Phase 3 Trial for Acute Graft Versus Host Disease Presented at 2018 ISSCR Annual Meeting

21/06/2018 - 12:00

NEW YORK and MELBOURNE, Australia, June 21, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced key Day 100 survival outcomes of its Phase 3 trial for remestemcel-L, an allogeneic [...]

Fennec Announces Publication of Pedmark(TM) Siopel 6 Clinical Data in the New England Journal of Medicine

21/06/2018 - 12:00

SIOPEL 6 met primary endpoint (p=0.002) 48% reduction in the incidence of hearing loss No evidence of tumor protection RESEARCH TRIANGLE PARK, N.C., June 21, 2018 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: [...]

Wright Medical Group N.V. Announces Private Placement of $675 Million of 1.625% Cash Convertible Senior Notes Due 2023

21/06/2018 - 12:00

AMSTERDAM, The Netherlands, June 21, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ:WMGI) (the “Company”) today announced that it has entered into privately negotiated agreements among the Company, Wright [...]